Loss of FBXO7 results in a Parkinson's-like dopaminergic degeneration via an RPL23-MDM2-TP53 pathway. (2019)

First Author: Stott SR
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/path.5312

PubMed Identifier: 31144295

Publication URI: http://europepmc.org/abstract/MED/31144295

Type: Journal Article/Review

Volume: 249

Parent Publication: The Journal of pathology

Issue: 2

ISSN: 0022-3417